Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Tokyo VD who wrote (2477)	2/22/1998 10:47:00 PM
From: Peter Goss	Read Replies (2) \| Respond to of 7041

I am curious about the NDA filing (or lack of it). If the Pfizer product is approved shortly, and ZONA has not filed, then Vasomax has to go through the normal approval process, not the expedited review, correct? Wouldn't that be a major setback? Also in that 10Q Bruce or someone posted, it said all the data was gathered; if that is so, why hasn't the filing been made? Are they waiting until the eleventh hour just to make their shareholders nervous? If I were doing the filing, seems like it would be prudent not to wait until the last week. But, then again, if Bill et al are correct, then maybe no filing is coming at all. Makes you wonder. Peter